231 related articles for article (PubMed ID: 16997145)
1. Inhibitors of de novo folate enzymes in Plasmodium falciparum.
Nzila A
Drug Discov Today; 2006 Oct; 11(19-20):939-44. PubMed ID: 16997145
[TBL] [Abstract][Full Text] [Related]
2. Molecular epidemiology of malaria in Cameroon. XXVII. Clinical and parasitological response to sulfadoxine-pyrimethamine treatment and Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase alleles in Cameroonian children.
Tahar R; Basco LK
Acta Trop; 2007 Aug; 103(2):81-9. PubMed ID: 17640607
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of resistance of malaria parasites to antifolates.
Gregson A; Plowe CV
Pharmacol Rev; 2005 Mar; 57(1):117-45. PubMed ID: 15734729
[TBL] [Abstract][Full Text] [Related]
4. The implication of dihydrofolate reductase and dihydropteroate synthetase gene mutations in modification of Plasmodium falciparum characteristics.
A-Elbasit IE; Alifrangis M; Khalil IF; Bygbjerg IC; Masuadi EM; Elbashir MI; Giha HA
Malar J; 2007 Aug; 6():108. PubMed ID: 17686173
[TBL] [Abstract][Full Text] [Related]
5. Antifolates can have a role in the treatment of Plasmodium vivax.
Hawkins VN; Joshi H; Rungsihirunrat K; Na-Bangchang K; Sibley CH
Trends Parasitol; 2007 May; 23(5):213-22. PubMed ID: 17368986
[TBL] [Abstract][Full Text] [Related]
6. Selection of antifolate-resistant Plasmodium falciparum by sulfadoxine-pyrimethamine treatment and infectivity to Anopheles mosquitoes.
Méndez F; Herrera S; Murrain B; Gutiérrez A; Moreno LA; Manzano M; Muñoz A; Plowe CV
Am J Trop Med Hyg; 2007 Sep; 77(3):438-43. PubMed ID: 17827356
[TBL] [Abstract][Full Text] [Related]
7. Exploring the folate pathway in Plasmodium falciparum.
Hyde JE
Acta Trop; 2005 Jun; 94(3):191-206. PubMed ID: 15845349
[TBL] [Abstract][Full Text] [Related]
8. Translational up-regulation of antifolate drug targets in the human malaria parasite Plasmodium falciparum upon challenge with inhibitors.
Nirmalan N; Sims PF; Hyde JE
Mol Biochem Parasitol; 2004 Jul; 136(1):63-70. PubMed ID: 15138068
[TBL] [Abstract][Full Text] [Related]
9. Elucidation of sulfadoxine resistance with structural models of the bifunctional Plasmodium falciparum dihydropterin pyrophosphokinase-dihydropteroate synthase.
de Beer TA; Louw AI; Joubert F
Bioorg Med Chem; 2006 Jul; 14(13):4433-43. PubMed ID: 16517168
[TBL] [Abstract][Full Text] [Related]
10. Transfection studies to explore essential folate metabolism and antifolate drug synergy in the human malaria parasite Plasmodium falciparum.
Wang P; Wang Q; Aspinall TV; Sims PF; Hyde JE
Mol Microbiol; 2004 Mar; 51(5):1425-38. PubMed ID: 14982635
[TBL] [Abstract][Full Text] [Related]
11. Distinct haplotypes of dhfr and dhps among Plasmodium falciparum isolates in an area of high level of sulfadoxine-pyrimethamine (SP) resistance in eastern Sudan.
Al-Saai S; Kheir A; Abdel-Muhsin AM; Al-Ghazali A; Nwakanma D; Swedberg G; Babiker HA
Infect Genet Evol; 2009 Sep; 9(5):778-83. PubMed ID: 19379843
[TBL] [Abstract][Full Text] [Related]
12. Identification of the optimal third generation antifolate against P. falciparum and P. vivax.
Hunt SY; Detering C; Varani G; Jacobus DP; Schiehser GA; Shieh HM; Nevchas I; Terpinski J; Sibley CH
Mol Biochem Parasitol; 2005 Dec; 144(2):198-205. PubMed ID: 16181688
[TBL] [Abstract][Full Text] [Related]
13. Basis for antifolate action and resistance in malaria.
Yuthavong Y
Microbes Infect; 2002 Feb; 4(2):175-82. PubMed ID: 11880049
[TBL] [Abstract][Full Text] [Related]
14. 2,4-diaminopteridine-based compounds as precursors for de novo synthesis of antifolates: a novel class of antimalarials.
Nduati E; Hunt S; Kamau EM; Nzila A
Antimicrob Agents Chemother; 2005 Sep; 49(9):3652-7. PubMed ID: 16127035
[TBL] [Abstract][Full Text] [Related]
15. Folate metabolism in malaria.
Ferone R
Bull World Health Organ; 1977; 55(2-3):291-8. PubMed ID: 338184
[TBL] [Abstract][Full Text] [Related]
16. The past, present and future of antifolates in the treatment of Plasmodium falciparum infection.
Nzila A
J Antimicrob Chemother; 2006 Jun; 57(6):1043-54. PubMed ID: 16617066
[TBL] [Abstract][Full Text] [Related]
17. A rapid assay for dihydropteroate synthase activity suitable for identification of inhibitors.
Fernley RT; Iliades P; Macreadie I
Anal Biochem; 2007 Jan; 360(2):227-34. PubMed ID: 17134675
[TBL] [Abstract][Full Text] [Related]
18. Resistance to sulphadrug-based antifolate therapy in malaria: are we looking in the right place?
Platteeuw JJ
Trop Med Int Health; 2006 Jun; 11(6):804-8. PubMed ID: 16772001
[TBL] [Abstract][Full Text] [Related]
19. Response of Plasmodium falciparum to cotrimoxazole therapy: relationship with plasma drug concentrations and dihydrofolate reductase and dihydropteroate synthase genotypes.
Khalil IF; Rønn AM; Alifrangis M; Gabar HA; Jelinek T; Satti GM; Bygbjerg IC
Am J Trop Med Hyg; 2005 Jul; 73(1):174-7. PubMed ID: 16014854
[TBL] [Abstract][Full Text] [Related]
20. In silico screening against wild-type and mutant Plasmodium falciparum dihydrofolate reductase.
Fogel GB; Cheung M; Pittman E; Hecht D
J Mol Graph Model; 2008 Apr; 26(7):1145-52. PubMed ID: 18037315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]